Deceased organ donor screening for human immunodeficiency virus, hepatitis B virus and hepatitis C virus: Discordant serology and nucleic acid testing results.
Nicole M TheodoropoulosMarek J NowickiClaudia Chinchilla-ReyesSara DionneAndrés JaramilloTom MoneRichard HaszMartin D JendrisakDaniela P LadnerMichael G IsonPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2018)
This study highlights the importance of robust quality assurance to minimize NRP NAT results. NAT may allow for increased utilization of organs from HBV- and HCV-seropositive, NAT-negative donors.